Which stocks are experiencing notable movement on Monday?
By Mill Chart
Last update: Apr 15, 2024
Which stocks are moving on Monday?
Gainers
| Ticker | Change | Comment |
|---|---|---|
| WISA | 9.0K% | WISA TECHNOLOGIES INC (NASDAQ:WISA) witnessed a notable 9.0K% uptick in its shares, reaching $1.84 during Monday's session. In the last month the stock lost 48.99%. |
| GRRR | 808.0% | GORILLA TECHNOLOGY GROUP INC's (NASDAQ:GRRR) stock price is advancing with 808.0% to a price of $5.45. A press release (Gorilla Technology Lanner Launch Cutting-Edge Security Convergence Devices to Transform Cybersecurity Landscape) was released earlier today. |
| MRIN | 403.0% | Investors celebrated as MARIN SOFTWARE INC (NASDAQ:MRIN) experienced a 403.0% rise in its shares, closing at $2.46 during Monday's session. Shareholders saw the stock price going 54.19% higher in the past month. |
| KAVL | 212.0% | KAIVAL BRANDS INNOVATIONS GR's (NASDAQ:KAVL) shares rose 212.0% to $8.32. In the last month the share price increased with 27.14%. |
| LGVN | 46.15% | Positive market sentiment drove LONGEVERON INC-A's (NASDAQ:LGVN) stock price up by 46.15% to $2.47 during Monday's session. The stock is trading 63.26% lower than a month ago. |
| SPCB | 41.21% | SUPERCOM LTD (NASDAQ:SPCB) witnessed a notable 41.21% uptick in its shares, reaching $0.4 during Monday's session. In the last month the share price increased with 68.81%. |
| HUBC | 35.38% | In an impressive move, HUB CYBER SECURITY LTD's (NASDAQ:HUBC) shares recorded a 35.38% increase, closing at $1.76 during Monday's session. The stock is trading 21.5% higher than a month ago. |
| SNGX | 34.14% | SOLIGENIX INC's (NASDAQ:SNGX) shares rose 34.14% to $0.52. In the last month the stock lost 39.37%. |
| JAGX | 31.34% | JAGUAR HEALTH INC (NASDAQ:JAGX) witnessed a notable 31.34% uptick in its shares, reaching $0.12 during Monday's session. Shareholders saw the stock price going 20.24% higher in the past month. |
| PROK | 30.86% | PROKIDNEY CORP's (NASDAQ:PROK) shares rose 30.86% to $2.29 during Monday's session. In the last month the stock gained 28.68%. |
For the full top gainers list go to our top gainers page.
Losers
| Ticker | Change | Comment |
|---|---|---|
| MRNS | -79.66% | MARINUS PHARMACEUTICALS INC's (NASDAQ:MRNS) stock price is declining with 79.66% to a price of $1.53. A press release (Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results) was released earlier today. |
| SAVAW | -79.05% | The market experienced a 79.05% downturn in CASSAVA SCIENCES INC-28's (NASDAQ:SAVAW) stock price, closing at $1.06 during Monday's session. The stock is trading 43.78% lower than 3 months ago. |
| MAPSW | -31.97% | Investors witnessed a 31.97% decrease in WM TECHNOLOGY INC-CW24's (NASDAQ:MAPSW) stock price, which closed at $0.05 during Monday's session. In the last month the share price increased with 30.55%. |
| SWVL | -27.81% | The market experienced a 27.81% downturn in SWVL HOLDINGS CORP's (NASDAQ:SWVL) stock price, closing at $9.58 during Monday's session. The stock is trading 88.23% higher than a month ago. |
| KULR | -23.83% | KULR TECHNOLOGY GROUP INC's (NYSEARCA:KULR) stock price decreased by 23.83% to $0.61. The stock is trading 371.0% higher than a month ago. |
| ORGNW | -23.5% | ORIGIN MATERIALS -CW26's (NASDAQ:ORGNW) stock price encountered a 23.5% decline, reaching $0.03 during Monday's session. The stock is trading 100.0% higher than a month ago. |
| ENLV | -22.15% | The market experienced a 22.15% downturn in ENLIVEX THERAPEUTICS LTD's (NASDAQ:ENLV) stock price, closing at $1.23 during Monday's session. In the last month the share price dropped with 61.65%. |
| JL | -20.68% | The market experienced a 20.68% downturn in J-LONG GROUP LTD's (NASDAQ:JL) stock price, closing at $0.62 during Monday's session. The stock is trading 54.39% lower than a month ago. |
| RLYB | -18.64% | RALLYBIO CORP's (NASDAQ:RLYB) shares fell 18.64% to $1.79 during Monday's session. In the last month the share price increased with 37.93%. |
| CZOO | -18.18% | The market experienced a downward movement in CAZOO GROUP LTD's (NYSE:CZOO) stock price, closing at $7.95 with a 18.18% decrease during Monday's session. Shareholders saw the stock price going 332.0% higher in the past month. |
For the full top loser list go to our top losers page.
ENLIVEX THERAPEUTICS LTD
NASDAQ:ENLV (4/29/2024, 7:00:01 PM)
After market: 1.6 -0.06 (-3.61%)1.66
+0.22 (+15.28%)
ENLV News
20 hours ago - Enlivex Therapeutics LtdEnlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events8 days ago - Enlivex Therapeutics LtdEnlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis
13 days ago - ChartmillOn Wednesday, there are stocks with unusual volume. Let's take a look.Let's have a look at the stocks with an unusual volume in today's session.
14 days ago - Enlivex Therapeutics LtdEnlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee OsteoarthritisNes-Ziona, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Danish Medicines Agency (DKMA) authorized the expansion into Denmark of the Company’s multi-country, randomized, controlled Phase I/II trial evaluating AllocetraTM in up to 160 patients with moderate to severe knee osteoarthritis. As previously announced, the Company received its first regulatory approval for this trial from the Israeli Ministry of Health (IMOH) in January.
15 days ago - ChartmillWhich stocks are experiencing notable movement on Monday?Which stocks are moving on Monday?
18 days ago - ChartmillThese stocks are moving in today's sessionFriday's session: top gainers and losers
19 days ago - Enlivex Therapeutics LtdEnlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with SepsisNes-Ziona, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming...
19 days ago - Enlivex Therapeutics LtdEnlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With SepsisAnalysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the safety...
25 days ago - InvestorPlaceENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023ENLV stock results show that Enlivex Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
